A

Anticancer Bioscience

28 employees

Anticancer Biosciences is an precision oncology company, applying synthetic lethal approaches to develop targeted cancer therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Life Science
Therapeutics
MYC
Natural Product Library
Drug Discovery
Health Care
Synthetic Lethality
Precision Oncology

Date founded

2016

Funding rounds raised

Total raised

$11M

from 1 investors over 1 rounds

A

Anticancer Bioscience raised $11M on October 14, 2021

Investors: 3 Rivers Capital, LLC

FAQ